Phase 2 data showed participants losing up to 18.7% of body weight at the highest dose over 46 weeks
Since semaglutide typically produces weight loss in the 10-15% range, many users actually experience improved urinary health over time, even if they face some indirect risk during the initial adjustment period
Furthermore, drug-caused hypoglycemia can lead to temporary visual disturbances, including floaters, due to changes in retinal blood flow or temporary retinal ischemia
Again, there were no new diagnoses within 1 year or during the L-carnitine supplementation, and medications were unchanged for at least 4 months before and during the study
v bnh c, tiu c vn, bnh c tim hoc t t ngi ln tui
[75] An observational study on patients with obesity and type 2 diabetes and heart failure with preserved ejection fraction reported that tirzepatide had a lower risk of hospitalization for heart failure and all-cause death combined than sitagliptin